« Guidant and the Independent Study | Main | TGN1412 - An Argument for Openness in Clincial Trials »
March 22, 2006
The Story of a Drug
In the Pipeline has an interesting story of the development and apparent decline of a new fixed-dose combination drug, BiDil. The drug in question is particularly interesting for its indication, which is, according to Lowe, probably the first "race-based pharmaceutical":
(Blogging may be slow in the next couple of days; I'm solo dad and my son has an ear infection, it seems. Hooray!)
March 22, 2006 in Experts & Science | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef00d8347d177853ef
Listed below are links to weblogs that reference The Story of a Drug:
Comments
Good luck on the dad front.
Dwayne
Posted by: Dwayne Clark | Mar 22, 2006 3:43:58 PM
